Fairfield, Bush & Co. Novo Nordisk A S Transaction History

Fairfield, Bush & Co.

$168 Billion
Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Novo Nordisk A S stock. As of the latest transaction made, Fairfield, Bush & Co. holds 18,484 shares of NVO stock, worth $1.57 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

18,484

Previous 16,180 14.24%

Holding current value

$1.57 Million

Previous $2.31 Billion 4.7%

% of portfolio

1.31%

Previous 1.38%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $274,337 - $335,047	2,304 Added 14.24%	18,484 $2.2 Billion
Q2 2024 Aug 15, 2024	BUY	$122.71 - $146.91 $88,105 - $105,481	718 Added 4.64%	16,180 $2.31 Billion
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $168,992 - $224,947	1,655 Added 11.99%	15,462 $1.99 Billion
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $729,890 - $876,816	8,315 Added 151.4%	13,807 $1.43 Billion
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $67,841 - $148,856	746 Added 15.72%	5,492 $499 Million
Q2 2023 Aug 15, 2023	SELL	$155.98 - $172.65 $3.59 Million - $3.97 Million	-23,000 Reduced 82.89%	4,746 $768 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $3.28 Million - $3.94 Million	24,750 Added 826.1%	27,746 $4.42 Billion
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $20,510 - $27,066	-200 Reduced 6.26%	2,996 $405 Million
Q4 2021 Feb 09, 2022	SELL	$95.88 - $117.08 $2.41 Million - $2.94 Million	-25,100 Reduced 88.71%	3,196 $358,000
Q2 2021 Aug 02, 2021	SELL	$67.66 - $84.76 $47,362 - $59,332	-700 Reduced 2.41%	28,296 $2.37 Million
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $109,911 - $124,268	-1,639 Reduced 5.35%	28,996 $1.95 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $135,766 - $156,825	-2,125 Reduced 6.49%	30,635 $2.14 Million
Q3 2020 Nov 18, 2020	SELL	$63.69 - $70.22 $93,942 - $103,574	-1,475 Reduced 4.31%	32,760 $2.27 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $216,890 - $251,717	-3,705 Reduced 9.77%	34,235 $2.24 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $212,678 - $278,554	-4,300 Reduced 10.18%	37,940 $2.28 Million
Q4 2019 Feb 12, 2020	SELL	$49.86 - $58.26 $29,916 - $34,956	-600 Reduced 1.4%	42,240 $2.44 Million
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $4,754 - $5,343	-100 Reduced 0.23%	42,840 $2.22 Million
Q2 2019 Aug 13, 2019	BUY	$46.79 - $52.47 $56,615 - $63,488	1,210 Added 2.9%	42,940 $2.19 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $155,306 - $176,310	-3,350 Reduced 7.43%	41,730 $2.18 Million
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $415 - $472	-10 Reduced 0.02%	45,080 $2.08 Million
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $28,056 - $30,744	-600 Reduced 1.31%	45,090 $2.13 Million
Q2 2018 Aug 16, 2018	SELL	$44.29 - $50.42 $255,553 - $290,923	-5,770 Reduced 11.21%	45,690 $2.11 Million
Q1 2018 May 09, 2018	SELL	$48.49 - $58.14 $306,699 - $367,735	-6,325 Reduced 10.95%	51,460 $2.53 Million
Q4 2017 Feb 22, 2018	BUY	$47.53 - $53.73 $153,284 - $173,279	3,225 Added 5.91%	57,785 $3.1 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $167,274 - $200,079	4,065 Added 8.05%	54,560 $2.63 Million
Q2 2017 Aug 15, 2017	BUY	N/A	50,495	50,495 $2.17 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account

Fairfield, Bush & Co. Novo Nordisk A S Transaction History